NCT00038675 2022-01-04Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateM.D. Anderson Cancer CenterPhase NA Completed125 enrolled 9 charts